Tofacitinib: Real-World Data and Treatment Persistence in Rheumatoid Arthritis
Ilaria Bertoldi,1 Roberto Caporali2 1Medical Department, Pfizer Italy, Rome, Italy; 2Department of Clinical Sciences and Community Health, University of Milan and ASST Pini-CTO Hospital, Milan, ItalyCorrespondence: Roberto CaporaliDepartment of Clinical Sciences and Community Health, University of M...
Guardado en:
Autores principales: | Bertoldi I, Caporali R |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bbee0d24648e4d5e8c2c40c9178099af |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical Outcomes in Iraqi Patients with Rheumatoid Arthritis Following Earlier or Later Treatment with Etanercept
por: Al-Ani N, et al.
Publicado: (2021) -
Treatment patterns, health care resource utilization and costs of rheumatoid arthritis patients in Italy: findings from a retrospective administrative database analysis
por: Fakhouri W, et al.
Publicado: (2018) -
The onset of rheumatoid arthritis following trauma
por: Brawer AE, et al.
Publicado: (2016) -
Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
por: Mysler E, et al.
Publicado: (2021) -
Real-World Treatment Patterns and Outcomes from an Electronic Medical Records Database for Patients with Rheumatoid Arthritis Treated with Repository Corticotropin Injection
por: Hayes K, et al.
Publicado: (2021)